A Phase 2a, Randomized, Partially-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of 24 Weeks of Treatment With Multiple Doses of JNJ-56136379 as Monotherapy and in Combination With a Nucleos(t)ide Analog in Subjects With Chronic Hepatitis B Virus Infection (JADE)

21st May 2018 - ongoing

Status: Active

Specialism: Liver.

Team: Dr Steve Ryder.

People
Photo Name Bio
dr-steve-ryder Dr Steve Ryder
Publications
Title
Grants
Title Amount